Overview

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

Status:
Terminated
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studies.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Dihydroxyphenylalanine